Skip to content

Clinical trials

Completed Phase 3 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 3 Status: Completed Clear all

186 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20012
20029
200315
20044
200510
200612
20076
200811
200911
20109
20118
20125
20137
20148
20158
20164
20179
20181
20197
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed186

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene12
Amgen11
Janssen Research & Development, LLC11
Fred Hutchinson Cancer Center7
Millennium Pharmaceuticals, Inc.7
Alliance for Clinical Trials in Oncology6
PETHEMA Foundation6
University of Arkansas6
Fondazione EMN Italy Onlus5
Bristol-Myers Squibb4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma186
Neoplasms, Plasma Cell44
Hodgkin Disease27
Lymphoma, Non-Hodgkin27
Leukemia, Lymphocytic, Chronic, B-Cell26
Lymphoma24
Lymphoma, Large B-Cell, Diffuse23
Lymphoma, Mantle-Cell23
Recurrence23
Precursor Cell Lymphoblastic Leukemia-Lymphoma22

Trials

Showing 1 to 25 of 186. Each trial links to its page on Pharma Observatory.

86 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.